Planes de vacunación en animales de compañía y sistemas de producción en equinos y bovinos

Vaccination protocols in companion animals and animal production systems in equines and bovines

La vacunación desempeña un rol esencial previniendo enfermedades, salvaguardando la salud y el bienestar de la población. Esta revisión tiene como objetivo diseñar los planes de vacunación para animales de compañía y sistemas de producción en equinos y bovinos ubicados en el departamento del Meta (Colombia). La vacunación puede brindar, en felinos y caninos, protección contra posibles agentes infectocontagiosos, zoonóticos en algunos casos, y así reducir las pérdidas de gastos veterinarios asociados al tratamiento de animales enfermos. En equinos es profiláctica para la encefalomielitis y la influenza equina, pudiendo evitar el sufrimiento del animal y las posibles pérdidas económicas; mientras que, en producción bovina puede ser altamente preventiva contra afecciones como brucelosis y fiebre aftosa, las cuales pueden tener consecuencias económicas graves en la industria. Por lo tanto, es de crucial importancia adoptar un enfoque sólido y claro en la prevención mediante programas de vacunación contextualizados, en este caso para el departamento del Meta.

1. Paranhos da Costa MJ, Tarazona Morales AM. Abordaje práctico sobre cómo mejorar el bienestar en los bovinos. Rev Colom Cienc Pecu. 2011; 24(3):347-359. https://doi.org/10.17533/udea.rccp.324693
2. Gizaw S, Desta H, Alemu B, Tegegne A, Wieland B. Importance of livestock diseases identified using participatory epidemiology in the highlands of Ethiopia. Trop Anim Health Prod. 2020; 52(4):1745-1757. https://doi.org/10.1007/s11250-019-02187-4
3. Layton DS, Choudhary A, Bean AGD. Breaking the chain of zoonoses through biosecurity in livestock. Vaccine. 2017; 35(44):5967-5973. https://doi:10.1016/j.vaccine.2017.07.110
4. Rodríguez M, Joseph S, Pfeffer M, Raghavan R, Wernery U. Immune response of horses to inactivated African horse sickness vaccines. BMC Vet Res. 2020; 16:322. https://doi.org/10.1186/s12917-020-02540-y
5. Bergmann M, Friedl Y, Hartmann K. Passive Immunisierung bei Hund und Katze. Tierarztliche Prax Ausg K. 2016; 44(4):287-292. https://doi:10.15654/tpk-160189
6. Lugelo A, Hampson K, Ferguson EA, Czupryna A, Bigambo M, Duamor CT, et al. Development of Dog Vaccination Strategies to Maintain Herd Immunity against Rabies. Viruses. 2022;14(4):830. https://doi.org/10.3390/v14040830
7. Oviedo-Pastrana M, Brunal-Tachack E, Doria-Ramos M, Oviedo-Socarras T. Análisis de indicadores epidemiológicos: Brucelosis bovina en la Costa Atlántica y Antioquia - Colombia, 2005-2013. Rev MVZ Cordoba. 2017; 22(supl):6034–6043. http://doi.org/10.21897/rmvz.1073
8. Tolosa-Quintero NJ, Loboa-Rodríguez NJ, Gutierrez-Lesmes OA, Góngora-Orjuela A. Indicador compuesto en salud: riesgo de transmisión del virus de la rabia. Rev de Salud Pública. 2018; 20(6):764–770. https://doi.org/10.15446/rsap.V20n6.74695
9. Kappes A, Tozooneyi T, Shakil G, Railey AF, McIntyre KM, Mayberry DE, et al. Livestock health and disease economics: a scoping review of selected literature. Front Vet Sci. 2023; 10. http://doi.org/10.3389/fvets.2023.1168649
10. Rivera AM, Sanchez-Vazquez MJ, Pituco EM, Buzanovsky LP, Martini M, Cosivi O. Advances in the eradication of foot-and-mouth disease in South America: 2011-2020. Front Vet Sci. 2023; 9:1024071. https://doi:10.3389/fvets.2022.1024071
11. WAHIS. Sistema Mundial de Información Zoosanitaria. World Organisation for Animal Health: 2023. https://wahis.woah.org/#/event-management
12. Sah R, Siddiq A, Al-Ahdal T, Maulud SQ, Mohanty A, Padhi BK, et al. The emerging scenario for the Eastern equine encephalitis virus and mitigation strategies to counteract this deadly mosquito-borne zoonotic virus, the cause of the most severe arboviral encephalitis in humans—an update. Front Vet Sci. 2023; 3. http://dx.doi.org/10.3389/fitd.2022.1077962
13. Agudelo-Suárez AN, Villamil-Jiménez LC. Políticas públicas de zoonosis en Colombia, 1975-2014. Un abordaje desde la ciencia política y la salud pública. Revista de Salud Pública. 2017; 19(6):787–794 https://doi.org/10.15446/rsap.V19n6.72109
14. Tago D, Sall B, Lancelot R, Pradel J. VacciCost – A tool to estimate the resource requirements for implementing livestock vaccination campaigns. Application to peste des petits ruminants (PPR) vaccination in Senegal. Prev Vet Med. 2017; 144:13-19. https://doi.org/10.1016/j.prevetmed.2017.05.011
15. Tizard IR. Feline vaccines. Vaccines Vet. 2021; 167–178. https://doi.org/10.1016/B978-0-323-68299-2.00023-X
16. Larson LJ, Schultz RD. Canine and Feline Vaccinations and Immunology. Infectious Disease Management in Animal Shelters. John Wiley & Sons; 2021. http://doi.org/10.1002/9781119294382.ch9
17. Bergmann M, Schwertler S, Reese S, Speck S, Truyen U, Hartmann K. Respuesta de anticuerpos a la vacunación contra el virus de la panleucopenia felina en gatos adultos sanos. Revista de Medicina y Cirugía Felina. 2018; 20(12):1087-1093. https://doi.org/10.1177/1098612X1774774
18. Bergmann, Speck, Rieger, Truyen, Hartmann. Antibody response to feline Calicivirus vaccination in healthy adult cats. Viruses. 2019; 11(8):702. http://doi.org/10.3390/v11080702
19. Jas D, Frances-Duvert V, Brunet S, Oberli F, Guigal P-M, Poulet H. Evaluation of safety and immunogenicity of feline vaccines with reduced volume. Vaccine. 2021; 39(7):1051–1057. http://doi.org/10.1016/j.vaccine.2021.01.026
20. Stone AE, Brummet GO, Carozza EM, Kass PH, Petersen EP, Sykes J, et al. 2020 AAHA/AAFP Feline Vaccination Guidelines. J Feline Med Surg. 2020; 22(9):813-830. https://doi:10.1177/1098612x20941784
21. Crozet G, Rivière J, Canini L, Cliquet F, Robardet E, Dufour B. Evaluation of the worldwide occurrence of rabies in dogs and cats using a simple and homogenous framework for quantitative risk assessments of rabies reintroduction in disease-free areas through pet movements. Vet Sci. 2020; 7(4):207. http://doi.org/10.3390/vetsci7040207
22. Scherk MA, Ford RB, Gaskell RM, Hartmann K, Hurley KF, Lappin MR, et al. 2013 AAFP Feline Vaccination Advisory Panel Report. J Feline Med Surg. 2013; 15(9):785-808. https://doi.org/10.1177/1098612X13500429
23. Hartmann K, Day MJ, Thiry E, Lloret A, Frymus T, Addie D, et al. Feline injection-site sarcoma. J Feline Med Surg. 2015; 17(7):606-613. https://doi:10.1177/1098612x15588451
24. Vila Nova B, Cunha E, Sepúlveda N, Oliveira M, São Braz B, Tavares L, et al. Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study. BMC Vet Res. 2018; 14(1). http://doi.org/10.1186/s12917-018-1673-z
25. Cárdenas NC, Infante GP, Pacheco DAR, Diaz JPD, Wagner DCM, Dias RA, et al. Seroprevalence of Leptospira spp infection and its risk factors among domestic dogs in Bogotá, Colombia. Vet Anim Sci. 2018; 6:64-68. https://doi.org/10.1016/j.vas.2018.08.002
26. Escandón-Vargas K, Osorio L, Astudillo-Hernández M. Seroprevalence and factors associated with Leptospira infection in an urban district of Cali, Colombia. Cad Saude Publica. 2017; 33(5). https://doi.org/10.1590/0102-311X00039216
27. Decaro N, Buonavoglia C, Barrs VR. Canine parvovirus vaccination and immunisation failures: Are we far from disease eradication?. Vet Microbiol. 2020; 247:108760. https://doi.org/10.1016/j.vetmic.2020.108760
28. Wilson S, Siedek E, Thomas A, King V, Stirling C, Plevová E, et al. Influence of maternally-derived antibodies in 6-week old dogs for the efficacy of a new vaccine to protect dogs against virulent challenge with canine distemper virus, adenovirus or parvovirus. Trials Vaccinol. 2014; 3:107–113. https://doi.org/10.1016/j.trivac.2014.06.001
29. Carreño LA, Salas D, Beltrán KB. Prevalencia de leptospirosis en Colombia: revisión sistemática de literatura. Rev Salud Pública. 2017; 19(2):204-209. https://doi.org/10.15446/rsap.v19n2.54235
30. Gutiérrez JD, Martínez-Vega RA, Botello H, Ruiz-Herrera FJ, Arenas-López LC, Hernandez-Tellez KD. Environmental and socioeconomic determinants of leptospirosis incidence in Colombia. Cad Saude Publica. 2019; 35(3). https://doi.org/10.1590/0102-311X00118417
31. Pérez-García J, Agudelo-Flórez P, Parra-Henao GJ, Ochoa JE, Arboleda M. Incidencia y subregistro de casos de leptospirosis diagnosticados con tres métodos diferentes en Urabá, Colombia. Biomédica. 2019; 39:150-162. https://doi.org/10.7705/biomedica.v39i0.4577
32. Góngora A, Parra JL, Aponte LH, Gómez LA. Seroprevalencia de Leptospira spp. en grupos de población de Villavicencio, Colombia. Rev Salud Pública. 2008; 10:269-278. https://doi.org/10.1590/s0124-00642008000200007
33. Desanti-Consoli H, Bouillon J, Chapuis RJJ. Equids’ core vaccines guidelines in North America: Considerations and prospective. Vaccines (Basel). 2022; 10(3):398. https://doi.org/10.3390/vaccines10030398
34. Guzmán-Terán C, Calderón-Rangel A, Rodriguez-Morales A, Mattar S. Venezuelan equine encephalitis virus: the problem is not over for tropical America. Ann Clin Microbiol Antimicrob. 2020; 19(1). https://doi.org/10.1186/s12941-020-00360-4
35. Dupuy LC, Richards MJ, Livingston BD, Hannaman D, Schmaljohn CS. A multiagent Alphavirus DNA vaccine delivered by intramuscular electroporation elicits robust and durable virus-specific immune responses in mice and rabbits and completely protects mice against lethal Venezuelan, western, and eastern equine encephalitis virus aerosol challenges. J Immunol Res. 2018; 2018:1–15. https://doi.org/10.1155/2018/8521060
36. AAEP. Vaccinations for adult horses. American Association of Equine Practitioners; 2015. https://aaep.org/sites/default/files/Guidelines/Adult%20Vaccination%20Chart_8.12.16.pdf
37. AAEP. Vaccinations for foals. American Association of Equine Practitioners; 2020. https://aaep.org/sites/default/files/Documents/Foal_Vaccination_Chart_FINAL_0520.pdf
38. Donachie D, Hamilton K. Exploring innovative approaches to improving sustainable management of animal health emergencies. World Organisation for Animal Health; 2020. http://doi.org/10.20506/bull.2020.2.3141
39. Oladunni FS, Oseni SO, Martinez-Sobrido L, Chambers TM. Equine Influenza Virus and Vaccines. Viruses. 2021; 13(8):1657. https://doi.org/10.3390/v13081657
40. Dilai M, Piro M, Mehdi El Harrak, Stéphanie Fougerolle, Dehhaoui M, Asmaa Dikrallah, et al. Impact of Mixed Equine Influenza Vaccination on Correlate of Protection in Horses. Vaccines. 2018; 6(4):71-71. https://doi.org/10.3390/vaccines6040071
41. Paillot R. A systematic review of recent advances in equine influenza vaccination. Vaccines (Basel). 2014; 2(4):797–831.https://doi.org/10.3390/vaccines2040797
42. Favaro PF, Reischak D, Brandao PE, Villalobos EMC, Cunha EMS, Lara MCCSH, et al. Comparison among three different serological methods for the detection of equine influenza virus infection. Rev Sci Tech. 2017; 36(3):789–798. http://dx.doi.org/10.20506/rst.36.3.2714
43. Cullinane A, Gahan J, Walsh C, et al. Evaluación de los protocolos actuales de vacunación contra la influenza equina antes del embarque, guiados por las normas de la OIE. Vacunas (Basilea). 2020; 8(1):107. https://doi:10.3390/vaccines8010107
44. Paillot R, Rash N, Garrett D, Prowse-Davis L, Montesso F, Cullinane A, et al. How to meet the last OIE expert surveillance panel recommendations on equine influenza (EI) vaccine composition: A review of the process required for the recombinant canarypox-based EI vaccine. Pathogens. 2016; 5(4):64. https://doi.org/10.3390/pathogens5040064
45. Gonzalez-Obando J, Forero JE, Zuluaga-Cabrera AM, Ruiz-Saenz J. Equine Influenza Virus: An Old Known Enemy in the Americas. Vaccines (Basel). 2022; 10(10):1718. https://doi:10.3390/vaccines10101718
46. Paillot R, Pitel PH, Pronost S, Legrand L, Fougerolle S, Jourdan M, et al. Florida clade 1 equine influenza virus in France. Vet Rec. 2019; 184(3):101. https://doi.org/10.1136/vr.l1203
47. Blanco-Lobo P, Rodriguez L, Reedy S, Oladunni FS, Nogales A, Murcia PR, et al. A Bivalent Live-Attenuated Vaccine for the Prevention of Equine Influenza Virus. Viruses. 2019; 11(10):933. https://doi: 10.3390/v11100933
48. Heidary M, Dashtbin S, Ghanavati R, Mahdizade Ari M, Bostanghadiri N, Darbandi A, et al. Evaluation of brucellosis vaccines: A comprehensive review. Front Vet Sci. 2022; 9:925773. https://doi.org/10.3389/fvets.2022.925773
49. Aida V, Pliasas VC, Neasham PJ, North JF, McWhorter KL, Glover SR, et al. Novel vaccine technologies in veterinary medicine: A herald to human medicine vaccines. Front Vet Sci. 2021; 8:654289. https://doi.org/10.3389/fvets.2021.654289
50. Giraldo-Ramirez S, Rendon-Marin S, Ruiz-Saenz J. A concise review on certain important veterinary viruses in the Americas. Rev MVZ Cordoba. 2021; 26(2):e1965. https://doi.org/10.21897/rmvz.1965
51. Avila-Granados LM, Garcia-Gonzalez DG, Zambrano-Varon JL, Arenas-Gamboa AM. Brucellosis in Colombia: Current status and challenges in the control of an endemic disease. Front Vet Sci. 2019; 6:321. https://doi.org/10.3389/fvets.2019.00321
52. Dewell G, Gorden P. Beef and Dairy Cattle Vaccination Programs. 2016. https://store.extension.iastate.edu/product/14496
53. Waldner DN, Kirkpatrick J, Lehenbauer TW. Recommended Vaccination Schedules for a Comprehensive Dairy Herd Health Program. 2017. https://extension.okstate.edu/fact-sheets/recommended-vaccination-schedules-for-a-comprehensive-dairy-herd-health-program.html
54. BCRC. Vaccination of the Beef Herd. Beef Cattle Research Council. 2023. https://www.beefresearch.ca/topics/vaccination-of-the-beef-herd/
55. Lu Z, Yu S, Wang W, Chen W, Wang X, Wu K, et al. Development of Foot-and-Mouth Disease Vaccines in Recent Years. Vaccines. 2022; 10(11):1817. https://doi.org/10.3390/vaccines10111817
56. Rodriguez-Vivas RI, Trees AJ, Rosado-Aguilar JA, Villegas-Perez SL, Hodgkinson JE. Evolution of acaricide resistance: Phenotypic and genotypic changes in field populations of Rhipicephalus (Boophilus) microplus in response to pyrethroid selection pressure. Int J Parasitol. 2011; 41(8):895-903. https://doi.org/10.1016/j.ijpara.2011.03.012
57. Jaramillo Hernández DA. Importancia de la vacunación dentro del manejo integrado de Rhipicephalus microplus en bovinos. Rev Sist Prod Agroecol. 2022; 13(1):48-63. https://doi.org/10.22579/22484817.884
58. Suarez M, Rubi J, Pérez D, Cordova V, Salazar Y, Vielma A, et al. High impact and effectiveness of GavacTM vaccine in the national program for control of bovine ticks Rhipicephalus microplus in Venezuela. Livest Sci. 2016; 187:48–52. https://doi.org/10.1016/j.livsci.2016.02.005
59. Zaragoza NE, Orellana CA, Moonen GA, Moutafis G, Marcellin E. Producción de vacunas para proteger a los animales contra los clostridios patógenos. Toxinas (Basilea). 2019; 11(9):525. https://doi:10.3390/toxinas11090525
60. Lazurko MM, Erickson NEN, Campbell JR, Gow S, Waldner CL. Vaccine use in Canadian cow-calf herds and opportunities for improvement. Front Vet Sci. 2023; 10:1235942. http://doi.org/10.3389/fvets.2023.1235942